A. Buck

发表

Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures

H. Schirrmeister, G. Glatting, K. Nuessle, 2001, European Journal of Nuclear Medicine.

Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography.

H. Schirrmeister, S. Reske, A. Guhlmann, 2001, Thyroid : official journal of the American Thyroid Association.

Initial results in the assessment of multiple myeloma using 18F-FDG PET

H. Döhner, H. Schirrmeister, S. Reske, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Elevated FDG uptake in the lactating human breast.

H. Schirrmeister, S. Reske, A. Buck, 2001, Clinical nuclear medicine.

Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?

T. Mattfeldt, H. Schirrmeister, S. Reske, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis.

H. Schirrmeister, S. Reske, A. Guhlmann, 2002, Cancer biotherapy & radiopharmaceuticals.

Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells.

S. Reske, A. Buck, M. Bachem, 2001, Nucleic acids research.

Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells.

A. Buck, M. Ramadani, G. Adler, 2005, Gastroenterology.

Human Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-Imaging

T. Walles, A. Buck, R. Bundschuh, 2016, PloS one.

Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound

A. Buck, M. Fassnacht, Anne Hendricks, 2022, Langenbeck's Archives of Surgery.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

M. Lux, M. Beckmann, P. Fasching, 2018, Geburtshilfe und Frauenheilkunde.

Evaluation of diagnostic efficacy for localization of parathyroid adenoma in patients with primary hyperparathyroidism undergoing repeat surgery

A. Buck, C. Germer, Anne Hendricks, 2021, Langenbeck's Archives of Surgery.

Chapter 11 – Melanoma

A. Buck, A. Rezaee, M. Beheshti, 2018 .

Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer

H. Schirrmeister, G. Glatting, C. Arslandemir, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Chapter 3 – Breast Cancer

Mohsen Beheshti, A. Buck, A. Rezaee, 2018 .

Chapter 4 – Gastroesophageal Cancer

A. Buck, A. Rezaee, M. Raderer, 2018 .

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study.

H. Döhner, G. Glatting, A. Buck, 2001, Blood.

Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients.

H. Schirrmeister, T. Kühn, K. Koretz, 2004, Cancer biotherapy & radiopharmaceuticals.

Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i.

G. Glatting, A. Buck, S. Reske, 2006, Nuklearmedizin. Nuclear medicine.